https://www.npr.org/sections/health-shots/2021/01/06/953946994/doctors-encouraged-by-antibody-treatments-for-covid-19
Save stories to read later or create you own news web site to share with anyone
Notify me when I can create my custom news board
We will not share your email addressAlready on AllSides? Log In
AllSides members can bookmark any article and read it later. Save this article by becoming a member today!
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »AllSides members can instantly post news stories to their own personal page, making it easy to share and discuss information they care about. Become your own publisher by becoming a member today! Learn about My Front Page.
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »
Many doses of the monoclonal antibody drugs that treat mild to moderate COVID-19 are sitting unused around the country. There are logistical problems with providing these drugs and skepticism over whether they work. But two major health systems have had good success in deploying these medications, and they're reporting hopeful results.
Monoclonal antibodies, manufactured by Regeneron and Eli Lilly, have been available since just before Thanksgiving. The Food and Drug Administration authorized them for emergency use after studies suggested that they reduced the risk of hospitalization among people at elevated...
